Combining Lifestyle Modification and Liraglutide to Improve Weight Loss and Health Outcomes

Trial Profile

Combining Lifestyle Modification and Liraglutide to Improve Weight Loss and Health Outcomes

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 02 Jun 2017

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Acronyms MODEL
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 24 May 2017 Planned primary completion date changed from 1 Jan 2018 to 1 May 2018.
    • 24 May 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top